Japan to approve remdesivir for coronavirus patients in May

Prime Minister Shinzo Abe said Monday that Japan will soon approve the anti-viral drug remdesivir for the treatment of coronavirus patients, in what will be the country's first such decision amid the pandemic.A government official said separately that the drug will be approved as early as next month to treat patients with COVID-19, the respiratory illness caused by the novel coronavirus, as moves to develop therapeutic drugs and vaccines have been accelerating around the globe."The pharmaceutical approval (of remdesivir) will be possible shortly," Abe told a parliamentary session.Remdesivir…READ FULL ARTICLE